CIK 0001624326
- Non-accelerated filer
- Smaller reporting company
PAVmed Inc.
Sign in to watch- Ticker
- PAVM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471214177
- Phone
- +1 212-949-4319
- Business address
- 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10017
- Former names
- PAXmed Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | Aklog Lishan Chairman and CEO | Grant or award | +350,000 | 357,614 | ||
| 2025-09-30 | Aklog Lishan Chairman and CEO | Grant or award | +150,000 | 228,418 | ||
| 2022-03-28 | Aklog Lishan Chairman and CEO | Shares withheld for taxes | −79,636 | $1.18 | $94K | 176,277 |
| 2022-02-18 | Aklog Lishan Chairman and CEO | Grant or award · Employee stock option (right to buy) | +200,000 | 200,000 | ||
| 2021-04-01 | Aklog Lishan Chairman and CEO | Grant or award | +150,000 | 1,255,913 | ||
| 2021-03-18 | Aklog Lishan Chairman and CEO | Purchase | +7,500 | $4.31 | $32K | 1,105,913 |
| 2020-04-30 | Aklog Lishan Chairman and CEO | Grant or award | +250,000 | 1,098,413 | ||
| 2019-05-23 | Aklog Lishan Chairman and CEO | Purchase | +30,000 | $1.10 | $33K | 848,413 |
| 2019-03-15 | Aklog Lishan Chairman and CEO | Grant or award | +200,000 | 818,413 | ||
| 2018-08-28 | Aklog Lishan Chairman and CEO | Purchase | +30,000 | $1.18 | $35K | 618,413 |
| 2018-06-26 | Aklog Lishan Chairman and CEO | Other acquisition · Series Z Warrants | +968,019 | 2,078,285 | ||
| 2018-06-12 | Aklog Lishan Chairman and CEO | Option exercise | +1,018 | 2,303 | ||
| 2018-06-12 | Aklog Lishan Chairman and CEO | Option exercise | +980 | 2,280 | ||
| 2018-06-12 | Aklog Lishan Chairman and CEO | Option exercise · Subscription Rights (Right to Buy) | −1,018 | 0 | ||
| 2018-06-12 | Aklog Lishan Chairman and CEO | Option exercise · Series Z Warrants | +1,018 | 1,018 | ||
| 2018-06-12 | Aklog Lishan Chairman and CEO | Option exercise · Subscription Rights (Right to Buy) | −980 | 0 | ||
| 2018-06-12 | Aklog Lishan Chairman and CEO | Option exercise · Series Z Warrants | +980 | 980 | ||
| 2018-04-20 | Aklog Lishan Chairman and CEO | Gift · Series Z Warrants | −12,450 | 363,313 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Returned to the company · Warrants | −50,450 | 0 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Grant or award · Series Z Warrants | +25,225 | 25,225 |
Page 1 of 7 · 139 trades